NCT 02468024 (STABLE-MATES) A Randomized Phase III Study of Sub-lobar Resection Versus Stereotactic Ablative Radiotherapy in High Risk Patients With Stage I Non-Small Cell Lung Cancer (NSCLC), The STABLE-MATES Trial. Primary outcome measure is overall survival. Estimated enrollment is 272 patients.
JoLT-Ca Sublobar Resection (SR) Versus Stereotactic Ablative Radiotherapy (SAbR) for Lung Cancer (STABLE-MATES)
